Literature DB >> 23954968

Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Raman Bahal, Nicole Ali McNeer, Danith H Ly, W Mark Saltzman, Peter M Glazer.   

Abstract

The development of a new class of peptide nucleic acids (PNAs), i.e., gamma PNAs (γPNAs), creates the need for a general and effective method for its delivery into cells for regulating gene expression in mammalian cells. Here we report the antisense activity of a recently developed hydrophilic and biocompatible diethylene glycol (miniPEG)-based gamma peptide nucleic acid called MPγPNAs via its delivery by poly(lactide-co-glycolide) (PLGA)-based nanoparticle system. We show that MPγPNA oligomers designed to bind to the selective region of chemokine receptor 5 (CC R5) transcript, induce potent and sequence-specific antisense effects as compared with regular PNA oligomers. In addition, PLGA nanoparticle delivery of MPγPNAs is not toxic to the cells. The findings reported in this study provide a combination of γPNA technology and PLGA-based nanoparticle delivery method for regulating gene expression in live cells via the antisense mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954968      PMCID: PMC3771998          DOI: 10.4161/adna.25628

Source DB:  PubMed          Journal:  Artif DNA PNA XNA        ISSN: 1949-095X


  46 in total

Review 1.  Aspects of the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; H Yoo
Journal:  Curr Opin Mol Ther       Date:  2000-06

2.  Keeping the biotechnology of antisense in context.

Authors:  C A Stein
Journal:  Nat Biotechnol       Date:  1999-03       Impact factor: 54.908

3.  Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.

Authors:  U Koppelhus; V Zachar; P E Nielsen; X Liu; J Eugen-Olsen; P Ebbesen
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

4.  The mononucleotide-dependent, nonantisense mechanism of action of phosphodiester and phosphorothioate oligonucleotides depends upon the activity of an ecto-5'-nucleotidase.

Authors:  M Koziolkiewicz; E Gendaszewska; M Maszewska; C A Stein; W J Stec
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

5.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

6.  Strand invasion of mixed-sequence, double-helical B-DNA by γ-peptide nucleic acids containing G-clamp nucleobases under physiological conditions.

Authors:  Srinivas Rapireddy; Raman Bahal; Danith H Ly
Journal:  Biochemistry       Date:  2011-04-25       Impact factor: 3.162

7.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

8.  Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix.

Authors:  M A Guvakova; L A Yakubov; I Vlodavsky; J L Tonkinson; C A Stein
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

9.  Synthesis of conformationally preorganized and cell-permeable guanidine-based gamma-peptide nucleic acids (gammaGPNAs).

Authors:  Bichismita Sahu; Venugopal Chenna; Kira L Lathrop; Sufi M Thomas; Gerald Zon; Kenneth J Livak; Danith H Ly
Journal:  J Org Chem       Date:  2009-02-20       Impact factor: 4.354

10.  RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers.

Authors:  B Larrouy; C Boiziau; B Sproat; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

View more
  13 in total

Review 1.  Applications of PNA-laden nanoparticles for hematological disorders.

Authors:  Shipra Malik; Stanley Oyaghire; Raman Bahal
Journal:  Cell Mol Life Sci       Date:  2018-11-29       Impact factor: 9.261

Review 2.  Perspectives on conformationally constrained peptide nucleic acid (PNA): insights into the structural design, properties and applications.

Authors:  Chaturong Suparpprom; Tirayut Vilaivan
Journal:  RSC Chem Biol       Date:  2022-03-18

3.  Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.

Authors:  Alanna R Kaplan; Ha Pham; Yanfeng Liu; Stanley Oyaghire; Raman Bahal; Donald M Engelman; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2020-02-25       Impact factor: 5.852

4.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

5.  Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.

Authors:  Raman Bahal; Elias Quijano; Nicole A McNeer; Yanfeng Liu; Dinesh C Bhunia; Francesco Lopez-Giraldez; Rachel J Fields; William M Saltzman; Danith H Ly; Peter M Glazer
Journal:  Curr Gene Ther       Date:  2014       Impact factor: 4.391

Review 6.  Nanotechnology for delivery of peptide nucleic acids (PNAs).

Authors:  Anisha Gupta; Raman Bahal; Meera Gupta; Peter M Glazer; W Mark Saltzman
Journal:  J Control Release       Date:  2016-01-08       Impact factor: 9.776

7.  PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.

Authors:  Hannah P Luehmann; Lisa Detering; Brett P Fors; Eric D Pressly; Pamela K Woodard; Gwendalyn J Randolph; Robert J Gropler; Craig J Hawker; Yongjian Liu
Journal:  J Nucl Med       Date:  2016-01-21       Impact factor: 10.057

Review 8.  Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.

Authors:  Elias Quijano; Raman Bahal; Adele Ricciardi; W Mark Saltzman; Peter M Glazer
Journal:  Yale J Biol Med       Date:  2017-12-19

9.  Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold.

Authors:  Xing-Liang Zhao; Bi-Cheng Chen; Jin-Chao Han; Lai Wei; Xiao-Ben Pan
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

10.  Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids.

Authors:  Desiree-Faye Kaixin Toh; Kiran M Patil; Gang Chen
Journal:  J Vis Exp       Date:  2017-09-21       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.